#$%^&*AU2018203756A120180621.pdf#####ABSTRACT Compositions and methods for inducing tolerance and depleting B cells in a human are provided. This includes administering a genetically modified T cell expressing a CAR, wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signalling region and a CD3 zeta signalling domain.